Search

Your search keyword '"Naesens, Leslie"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Naesens, Leslie" Remove constraint Author: "Naesens, Leslie"
36 results on '"Naesens, Leslie"'

Search Results

3. A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome

4. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement

6. Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)

7. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

8. A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome

10. Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients

11. Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review.

13. Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders

14. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

15. Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

17. GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141

19. Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients

20. Additional file 2 of Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)

21. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

22. Additional file 1 of Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)

23. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

25. Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

26. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

27. Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency

28. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner

29. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.

31. What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

33. What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

34. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

35. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

36. Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders.

Catalog

Books, media, physical & digital resources